It hasnt been approved by the MHRA, so no UK doctor can legally prescribe it, on the NHS or privately
Yes, understanding factors like insulin resistance, inflammation, cortisol imbalance, nutrient deficiencies, gut health, and metabolic dysfunction can help improve long-term outcomes with peptide therapies
Major Findings: Produced substantial dose-dependent weight loss, with the highest dose achieving approximately 24% mean weight loss at 48 weeks
Most are mild and tend to improve as your body adjusts
When GLP-1s became popular for weight loss, the market saw a shortage of them, which is why the FDA allowed compounding pharmacies to begin formulating non-branded, compounded versions of them
One major challenge during this transition is the decrease in resting metabolic rate